Enggid, Darwina L.

HRN: 09-21-44  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2022
CEFUROXIME 1.5GM (VIAL)
11/15/2022
11/15/2022
IV
1.5
Now
Stat Cs
Waiting Final Action 
11/15/2022
CEFUROXIME 1.5GM (VIAL)
11/15/2022
11/16/2022
IV
1.5
Q8
Post CS
Waiting Final Action 
11/16/2022
CEFUROXIME 500MG (TAB)
11/16/2022
11/23/2022
ORAL
500
BID
Post Cs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: